Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
Blood Products Advisory Committee considers at-home HIV test; Protica QC personnel fail on supplement GMPs; FDA warns pregnancy test maker of GMP, labeling violations; FDA uncovers more tainted supplements sold online; NRDC request for BPA ban short on data.
You may also be interested in...
In Brief
OTC HIV tests inch closer; FDA investigates Plan B vending machine; Crest toothpaste brightens in one use; L’Oreal sues J&J, Merck for sunscreen patent infringement; more News In Brief.
FDA Shift On BPA May Tighten Squeeze On Infant Formula Manufacturers
FDA's shift in position regarding the safety of bisphenol A likely will expedite the trend toward BPA-free packaging among infant formula marketers, even though existing science does not demonstrate a proven threat to babies and children
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.